EpiBone

Meet an Unreasonable Venture

Creating bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.

Nina Tandon

CEO & Co-Founder at EpiBone

More about Nina »

Connect

epibone.com

Employees 21–50

Headquarters Jersey City, New Jersey, United States

EpiBone, Inc. is privately-held clinical-stage regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of cells to create living solutions that can become a seamless part of a patient’s body. EpiBone is currently developing a pipeline of bone, cartilage, and compound (bone and cartilage) products.

Health

Notable Achievements

IND approval by the FDA in July 2023 to go into Ph 1/2 clinical trials with our cartilage product.
Successful completion of our Ph 1/2 clinical trial of our bone product in August 2023.
$45.8M of equity funding and $3M in grant funding raised to date.

Currently Operating in Six Regions

Press Mentions

June 12, 2024

Rubbing Elbows with the Innovate 100 — A Personal Account

The article recounts a personal experience of attending the Innovate 100 event, highlighting networking opportunities with influential figures in the tech industry. The author shares insights...

Read on NJ Tech Weekly »

June 5, 2024

Global Innovators of Indian Origin (2023)

The blog highlights the achievements of global innovators of Indian origin in 2023. It showcases their groundbreaking contributions in various fields, emphasizing their impact on technology,...

October 25, 2023

Behind Nina Tandon — The Big Apple and the Biotech Founder

Nina Tandon, a biotech entrepreneur, shares her journey from growing up in New York City to founding her own company. She discusses the challenges she faced and the importance of diversity in the...

Read on Brown Girl Magazine »

July 24, 2023

EpiBone to Start Clinical Trials for Knee Cartilage Grown in Lab

/PRNewswire/ -- EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The...

Read on PRNewswire »

March 9, 2023

EpiBone, emerging biotech company, is relocating to Jersey City — and bringing nearly 100 jobs | ROI-NJ

EpiBone, an emerging biotechnology company co-founded and run by Nina Marie Tandon, is coming to Jersey City after the Board of the New Jersey Economic Development Authority (NJEDA) approved up to...

Read on ROI-NJ »

October 17, 2015

Why Peter Thiel Invested In New York Biotech Startup EpiBone

EpiBone uses stem cells to regrow damaged bones. After getting a PhD from Columbia, Nina Tandon returned to school for an MBA to form a company at the forefront of 'biology as design.'

Read on Inc.com »